343 related articles for article (PubMed ID: 29886241)
1. Analgesic effects of systemic fentanyl on cancer pain are mediated by not only central but also peripheral opioid receptors in mice.
Shinohara A; Andoh T; Saiki I; Kuraishi Y
Eur J Pharmacol; 2018 Aug; 833():275-282. PubMed ID: 29886241
[TBL] [Abstract][Full Text] [Related]
2. A low pKa ligand inhibits cancer-associated pain in mice by activating peripheral mu-opioid receptors.
Baamonde A; Menéndez L; González-Rodríguez S; Lastra A; Seitz V; Stein C; Machelska H
Sci Rep; 2020 Oct; 10(1):18599. PubMed ID: 33122720
[TBL] [Abstract][Full Text] [Related]
3. Biphalin preferentially recruits peripheral opioid receptors to facilitate analgesia in a mouse model of cancer pain - A comparison with morphine.
Lesniak A; Bochynska-Czyz M; Sacharczuk M; Benhye S; Misicka A; Bujalska-Zadrozny M; Lipkowski AW
Eur J Pharm Sci; 2016 Jun; 89():39-49. PubMed ID: 27094782
[TBL] [Abstract][Full Text] [Related]
4. Naloxone antagonizes the local antihyperalgesic effect of fentanyl in burnt skin of healthy humans.
Robertson LJ; Drummond PD; Hammond GR
J Pain; 2007 Jun; 8(6):489-93. PubMed ID: 17368995
[TBL] [Abstract][Full Text] [Related]
5. Blocking mu opioid receptors in the spinal cord prevents the analgesic action by subsequent systemic opioids.
Chen SR; Pan HL
Brain Res; 2006 Apr; 1081(1):119-25. PubMed ID: 16499888
[TBL] [Abstract][Full Text] [Related]
6. Effects of the local administration of selective mu-, delta-and kappa-opioid receptor agonists on osteosarcoma-induced hyperalgesia.
Baamonde A; Lastra A; Juárez L; García V; Hidalgo A; Menéndez L
Naunyn Schmiedebergs Arch Pharmacol; 2005 Nov; 372(3):213-9. PubMed ID: 16283255
[TBL] [Abstract][Full Text] [Related]
7. Analgesic activity and pharmacological characterization of N-[1-phenylpyrazol-3-yl]-N-[1-(2-phenethyl)-4-piperidyl] propenamide, a new opioid agonist acting peripherally.
Goicoechea C; Sánchez E; Cano C; Jagerovic N; Martín MI
Eur J Pharmacol; 2008 Oct; 595(1-3):22-9. PubMed ID: 18706410
[TBL] [Abstract][Full Text] [Related]
8. μ-Opioid receptors in primary sensory neurons are essential for opioid analgesic effect on acute and inflammatory pain and opioid-induced hyperalgesia.
Sun J; Chen SR; Chen H; Pan HL
J Physiol; 2019 Mar; 597(6):1661-1675. PubMed ID: 30578671
[TBL] [Abstract][Full Text] [Related]
9. Peripheral opioids act as analgesics in bone cancer pain in mice.
Menéndez L; Lastra A; Hidalgo A; Meana A; García E; Baamonde A
Neuroreport; 2003 May; 14(6):867-9. PubMed ID: 12858049
[TBL] [Abstract][Full Text] [Related]
10. A murine model of opioid-induced hyperalgesia.
Li X; Angst MS; Clark JD
Brain Res Mol Brain Res; 2001 Jan; 86(1-2):56-62. PubMed ID: 11165371
[TBL] [Abstract][Full Text] [Related]
11. Local analgesic effect of tramadol is not mediated by opioid receptors in early postoperative pain in rats.
Sousa AM; Ashmawi HA
Braz J Anesthesiol; 2015; 65(3):186-90. PubMed ID: 25925030
[TBL] [Abstract][Full Text] [Related]
12. Modulation of peripheral μ-opioid analgesia by σ1 receptors.
Sánchez-Fernández C; Montilla-García Á; González-Cano R; Nieto FR; Romero L; Artacho-Cordón A; Montes R; Fernández-Pastor B; Merlos M; Baeyens JM; Entrena JM; Cobos EJ
J Pharmacol Exp Ther; 2014 Jan; 348(1):32-45. PubMed ID: 24155346
[TBL] [Abstract][Full Text] [Related]
13. Acute and chronic fentanyl administration causes hyperalgesia independently of opioid receptor activity in mice.
Waxman AR; Arout C; Caldwell M; Dahan A; Kest B
Neurosci Lett; 2009 Oct; 462(1):68-72. PubMed ID: 19559072
[TBL] [Abstract][Full Text] [Related]
14. Sigma-1 receptors control immune-driven peripheral opioid analgesia during inflammation in mice.
Tejada MA; Montilla-García A; Cronin SJ; Cikes D; Sánchez-Fernández C; González-Cano R; Ruiz-Cantero MC; Penninger JM; Vela JM; Baeyens JM; Cobos EJ
Proc Natl Acad Sci U S A; 2017 Aug; 114(31):8396-8401. PubMed ID: 28716934
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of fentanyl citrate on the release of endothlin-1 induced by bradykinin in melanoma cells.
Andoh T; Shinohara A; Kuraishi Y
Pharmacol Rep; 2017 Feb; 69(1):139-142. PubMed ID: 27919002
[TBL] [Abstract][Full Text] [Related]
16. Mu-opioid and noradrenergic α(2)-adrenoceptor contributions to the effects of tapentadol on spinal electrophysiological measures of nociception in nerve-injured rats.
Bee LA; Bannister K; Rahman W; Dickenson AH
Pain; 2011 Jan; 152(1):131-139. PubMed ID: 21187272
[TBL] [Abstract][Full Text] [Related]
17. Naloxone can act as an analgesic agent without measurable chronic side effects in mice with a mutant mu-opioid receptor expressed in different sites of pain pathway.
Chou SH; Kao JH; Tao PL; Law PY; Loh HH
Synapse; 2012 Aug; 66(8):694-704. PubMed ID: 22407757
[TBL] [Abstract][Full Text] [Related]
18. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats.
Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS
Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929
[TBL] [Abstract][Full Text] [Related]
19. Involvement of peripheral mu opioid receptors in scratching behavior in mice.
Yamamoto A; Sugimoto Y
Eur J Pharmacol; 2010 Dec; 649(1-3):336-41. PubMed ID: 20863827
[TBL] [Abstract][Full Text] [Related]
20. Peripheral and central sites of action for anti-allodynic activity induced by the bifunctional opioid/NPFF receptors agonist BN-9 in inflammatory pain model.
Zhang R; Xu B; Zhang MN; Zhang T; Wang ZL; Zhao G; Zhao GH; Li N; Fang Q; Wang R
Eur J Pharmacol; 2017 Oct; 813():122-129. PubMed ID: 28755985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
